Cargando…

Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection

Chronic infection with the hepatitis B virus (HBV) can lead to liver failure and can cause liver cirrhosis and hepatocellular carcinoma (HCC). Reliable means for detecting and monitoring HBV infection are essential to identify patients in need of therapy and to prevent HBV transmission. Nanomaterial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shevtsov, Maxim, Zhao, Lili, Protzer, Ulrike, van de Klundert, Maarten A. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537685/ https://www.ncbi.nlm.nih.gov/pubmed/28753992 http://dx.doi.org/10.3390/v9070193

Ejemplares similares

Control of Hepatitis B Virus by Cytokines
por: Xia, Yuchen, et al.
Publicado: (2017)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Knolle, Percy A., et al.
Publicado: (2021)

Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion
por: von Olshausen, Gesa, et al.
Publicado: (2018)

Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications
por: Wettengel, Jochen M., et al.
Publicado: (2021)

Innate immune recognition and modulation in hepatitis D virus infection
por: Jung, Stephanie, et al.
Publicado: (2020)

Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data
por: Velkov, Stoyan, et al.
Publicado: (2020)

The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data
por: Velkov, Stoyan, et al.
Publicado: (2018)

Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA
por: Kim, Elena S., et al.
Publicado: (2022)

Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
por: Liu, Peter Jianrui, et al.
Publicado: (2020)

Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
por: Liu, Peter Jianrui, et al.
Publicado: (2020)

Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro
por: Xia, Yuchen, et al.
Publicado: (2017)

Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
por: Allweiss, Lena, et al.
Publicado: (2023)

Design of therapeutic vaccines: hepatitis B as an example
por: Kutscher, Sarah, et al.
Publicado: (2012)

Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells
por: Tu, Thomas, et al.
Publicado: (2022)

N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
por: Appelman, Monique D., et al.
Publicado: (2017)

IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection
por: Li, Yong, et al.
Publicado: (2017)

Hepatitis B Virus Protein X Induces Degradation of Talin-1
por: van de Klundert, Maarten A. A., et al.
Publicado: (2016)

Synchronised infection identifies early rate-limiting steps in the hepatitis B virus life cycle
por: Chakraborty, Anindita, et al.
Publicado: (2020)

HDVdb: A Comprehensive Hepatitis D Virus Database
por: Usman, Zainab, et al.
Publicado: (2020)

Viral hepatitis and liver cancer
por: Ringehan, Marc, et al.
Publicado: (2017)

Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection
por: Kosinska, Anna D., et al.
Publicado: (2019)

Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20
por: Stadler, Daniela, et al.
Publicado: (2021)

Correction to ‘Viral hepatitis and liver cancer’
por: Ringelhan, Marc, et al.
Publicado: (2018)

Nanoparticle Vaccines Against Infectious Diseases
por: Pati, Rashmirekha, et al.
Publicado: (2018)

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells
por: Vincent, Isabelle E., et al.
Publicado: (2011)

Concentration of Na(+)-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virus
por: Oswald, Andreas, et al.
Publicado: (2021)

Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting
por: Körber, Nina, et al.
Publicado: (2020)

One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
por: Schiwon, Maren, et al.
Publicado: (2018)

The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair
por: van de Klundert, Maarten A. A., et al.
Publicado: (2012)

Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity
por: Altstetter, Sebastian Maximilian, et al.
Publicado: (2021)

PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B
por: Bunse, Till, et al.
Publicado: (2022)

Blocking sense‐strand activity improves potency, safety and specificity of anti‐hepatitis B virus short hairpin RNA
por: Michler, Thomas, et al.
Publicado: (2016)

Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?
por: Protzer, U., et al.
Publicado: (2010)

Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes
por: Esser, Knud, et al.
Publicado: (2023)

Protein X of Hepatitis B Virus: Origin and Structure Similarity with the Central Domain of DNA Glycosylase
por: van Hemert, Formijn J., et al.
Publicado: (2011)

Efficient and reproducible depletion of hepatitis B virus from plasma derived extracellular vesicles
por: Jung, Stephanie, et al.
Publicado: (2020)

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection
por: Kosinska, Anna D., et al.
Publicado: (2021)

Editorial: Radiotheranostics: From basic research to clinical application
por: Gareev, Kamil G., et al.
Publicado: (2023)

Magnetic nanoparticles in theranostics of malignant melanoma
por: Shevtsov, Maxim, et al.
Publicado: (2021)

Reply to the Letter of Charre et al. “Mis-Genotyping of Some Hepatitis D Virus Genotype 2 and 5 Sequences Using HDVdb”
por: Usman, Zainab, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aphvsf3j7tbg1f03psc464h16u